These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

997 related items for PubMed ID: 24740547

  • 1. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D, HPV-039 study group.
    Int J Cancer; 2014 Dec 01; 135(11):2604-11. PubMed ID: 24740547
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study.
    Konno R, Tamura S, Dobbelaere K, Yoshikawa H.
    Cancer Sci; 2011 Apr 01; 102(4):877-82. PubMed ID: 21251162
    [Abstract] [Full Text] [Related]

  • 3. High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia.
    Rantshabeng PS, Tsima BM, Ndlovu AK, Motlhatlhedi K, Sharma K, Masole CB, Moraka NO, Motsumi K, Maoto-Mokote AKT, Eshetu AB, Tawe L, Gaolathe T, Moyo S, Kyokunda LT.
    BMC Infect Dis; 2024 Oct 15; 24(1):1163. PubMed ID: 39407130
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M, Zhao C.
    J Low Genit Tract Dis; 2011 Apr 15; 15(2):105-9. PubMed ID: 21317806
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK.
    J Gynecol Oncol; 2018 Jan 15; 29(1):e14. PubMed ID: 29185272
    [Abstract] [Full Text] [Related]

  • 6. Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial.
    Zhu FC, Chen W, Hu YM, Hong Y, Li J, Zhang X, Zhang YJ, Pan QJ, Zhao FH, Yu JX, Zhang YS, Yang X, Zhang CF, Tang H, Zhang H, Lebacq M, David MP, Datta SK, Struyf F, Bi D, Descamps D, HPV-039 study group.
    Int J Cancer; 2014 Dec 01; 135(11):2612-22. PubMed ID: 24740596
    [Abstract] [Full Text] [Related]

  • 7. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science.
    Allameh T, Moghim S, Asadi-Zeidabadi M.
    Arch Gynecol Obstet; 2011 Dec 01; 284(6):1509-13. PubMed ID: 21387088
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain.
    Otero-Motta AP, Ordóñez JL, González-Celador R, Rivas B, Macías Mdel C, Bullón A, Abad Mdel M.
    APMIS; 2011 Mar 01; 119(3):204-15. PubMed ID: 21284738
    [Abstract] [Full Text] [Related]

  • 9. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.
    Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, Pukkala E, Siitari-Mattila M, Struyf F, Nieminen P, Paavonen J, Dubin G, Dillner J.
    BMJ Open; 2017 Aug 18; 7(8):e015867. PubMed ID: 28821519
    [Abstract] [Full Text] [Related]

  • 10. Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran.
    Heydari N, Oskouee MA, Vaezi T, Shoja Z, Esmaeili HA, Hamkar R, Shahmahmoodi S, Jalilvand S.
    J Med Virol; 2018 Jan 18; 90(1):172-176. PubMed ID: 28786495
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.
    Vaccine; 2012 Jul 27; 30(35):5215-21. PubMed ID: 22713720
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age.
    Xi LF, Touré P, Critchlow CW, Hawes SE, Dembele B, Sow PS, Kiviat NB.
    Int J Cancer; 2003 Mar 01; 103(6):803-9. PubMed ID: 12516102
    [Abstract] [Full Text] [Related]

  • 13. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J.
    Diagn Cytopathol; 2017 May 01; 45(5):384-390. PubMed ID: 28247516
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France.
    Vaucel E, Coste-Burel M, Laboisse C, Dahlab A, Lopes P.
    Arch Gynecol Obstet; 2011 Oct 01; 284(4):989-98. PubMed ID: 21107591
    [Abstract] [Full Text] [Related]

  • 15. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.
    Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, VALGENT Study Group.
    J Clin Microbiol; 2013 May 01; 51(5):1458-64. PubMed ID: 23447632
    [Abstract] [Full Text] [Related]

  • 16. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
    Taku O, Mbulawa ZZA, Phohlo K, Garcia-Jardon M, Businge CB, Williamson AL.
    Viruses; 2021 Feb 11; 13(2):. PubMed ID: 33670231
    [Abstract] [Full Text] [Related]

  • 17. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.
    Jalilvand S, Shoja Z, Nourijelyani K, Tohidi HR, Hamkar R.
    J Med Virol; 2015 Feb 11; 87(2):287-95. PubMed ID: 25156655
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study.
    Wu EQ, Liu B, Cui JF, Chen W, Wang JB, Lu L, Niyazi M, Zhao C, Ren SD, Li CQ, Gong XZ, Smith JS, Belinson JL, Liaw KL, Velicer C, Qiao YL.
    Cancer Causes Control; 2013 Apr 11; 24(4):795-803. PubMed ID: 23397310
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP, Li N, Smith JS, Qiao YL.
    Int J STD AIDS; 2008 Feb 11; 19(2):106-11. PubMed ID: 18334063
    [Abstract] [Full Text] [Related]

  • 20. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
    Wang R, Guo XL, Wisman GB, Schuuring E, Wang WF, Zeng ZY, Zhu H, Wu SW.
    BMC Infect Dis; 2015 Jul 04; 15():257. PubMed ID: 26142044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.